Microwave ablation boosts immunotherapy in advanced liver cancer study
NCT ID NCT06581497
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 52 adults with advanced liver cancer to see if adding microwave ablation (MWA) to immunotherapy works better than immunotherapy alone. MWA uses heat to destroy tumors and may help the immune system fight cancer more effectively. The researchers measured how long patients lived without the cancer getting worse and overall survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second People's Hospital of Neijiang City
Neijiang, Sichuan, 641000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A made-to-order DNA vaccine takes aim at liver cancer's return
- Simple blood test aims to catch liver cancer before It's too late
- Engineered virus takes on liver cancer when standard treatment fails
- Ultrasound vs. MRI: which spots hidden liver cancer better?
- Epigenetic drug may re-sensitize liver tumors to immunotherapy
- New hope for liver cancer patients who failed immunotherapy?